• Users Online: 69
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents - Current issue
Coverpage
January-March 2018
Volume 1 | Issue 1
Page Nos. 1-36

Online since Tuesday, January 30, 2018

Accessed 6,451 times.
View as eBookView issue as eBook
Author Institution MappingAuthor Institution Mapping
CitationsIssue citations
Access StatisticsIssue statistics
RSS FeedRSS
Show all abstracts  Show selected abstracts  Export selected to  Add to my list
REVIEW ARTICLES  

A closer look at the bone marrow microenvironment in multiple myeloma p. 1
Julie Stakiw, Mark Bosch, Hadi Goubran
DOI:10.4103/2395-7182.203049  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Ursolic acid and quercetin: Promising anticancer phytochemicals with antimetastatic and antiangiogenic potential p. 9
Dharambir Kashyap, Hardeep Singh Tuli, Vivek Kumar Garg, Suhasini Bhatnagar, Anil K Sharma
DOI:10.4103/tme.tme_3_17  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Citations (1) ]  [Sword Plugin for Repository]Beta
ORIGINAL ARTICLES Top

Significance of phosphorylated epidermal growth factor receptor, matrix metalloproteinases, and E-cadherin in oral cancer p. 16
Bhairavi N Vajaria, Kinjal R Patel, Rasheedunnisa Begum, Jayendra B Patel, Franky D Shah, Prabhudas S Patel
DOI:10.4103/2395-7182.203050  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Role of human epidermal growth factor receptor 2 antagonist (Trastuzumab) in the management of nonmuscle-invasive urinary bladder carcinoma p. 25
Raafat Hegazy, Abdelmonem Hegazy, Mostafa Kamel, Ola El-Farargy, Nashwa Nawar, Ahmed El-Atar
DOI:10.4103/tme.tme_15_17  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Treatment with Src inhibitor dasatinib results in elevated metastatic potential in the 4T1 murine mammary carcinoma model p. 30
Veronica S Hughes, Dietmar W Siemann
DOI:10.4103/tme.tme_19_17  
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal